Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP650891.RAxfVXqKFfhJZRN2YPIosI2mYyqNdQ3xDw9EUGCr5ovqE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP650891.RAxfVXqKFfhJZRN2YPIosI2mYyqNdQ3xDw9EUGCr5ovqE130_assertion type Assertion NP650891.RAxfVXqKFfhJZRN2YPIosI2mYyqNdQ3xDw9EUGCr5ovqE130_head.
- NP650891.RAxfVXqKFfhJZRN2YPIosI2mYyqNdQ3xDw9EUGCr5ovqE130_assertion description "[Furthermore, some of the genes deregulated by the leukemogenic process reverted to their normal expression with demethylating and HDAC inhibitor treatment, highlighting the role of chromatin remodeling processes in AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650891.RAxfVXqKFfhJZRN2YPIosI2mYyqNdQ3xDw9EUGCr5ovqE130_provenance.
- NP650891.RAxfVXqKFfhJZRN2YPIosI2mYyqNdQ3xDw9EUGCr5ovqE130_assertion evidence source_evidence_literature NP650891.RAxfVXqKFfhJZRN2YPIosI2mYyqNdQ3xDw9EUGCr5ovqE130_provenance.
- NP650891.RAxfVXqKFfhJZRN2YPIosI2mYyqNdQ3xDw9EUGCr5ovqE130_assertion SIO_000772 18206229 NP650891.RAxfVXqKFfhJZRN2YPIosI2mYyqNdQ3xDw9EUGCr5ovqE130_provenance.
- NP650891.RAxfVXqKFfhJZRN2YPIosI2mYyqNdQ3xDw9EUGCr5ovqE130_assertion wasDerivedFrom befree-2016 NP650891.RAxfVXqKFfhJZRN2YPIosI2mYyqNdQ3xDw9EUGCr5ovqE130_provenance.
- NP650891.RAxfVXqKFfhJZRN2YPIosI2mYyqNdQ3xDw9EUGCr5ovqE130_assertion wasGeneratedBy ECO_0000203 NP650891.RAxfVXqKFfhJZRN2YPIosI2mYyqNdQ3xDw9EUGCr5ovqE130_provenance.